Get the Stockscreener App
1.71
3.93%
-0.07
After Hours:
1.75
0.04
+2.34%
Microbot Medical Inc stock is traded at $1.71, with a volume of 1.27M.
It is down -3.93% in the last 24 hours and down -22.97% over the past month.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
See More
Previous Close:
$1.78
Open:
$1.76
24h Volume:
1.27M
Relative Volume:
0.71
Market Cap:
$114.85M
Revenue:
-
Net Income/Loss:
$-13.14M
P/E Ratio:
-5.5955
EPS:
-0.3056
Net Cash Flow:
$-13.11M
1W Performance:
-7.57%
1M Performance:
-22.97%
6M Performance:
-6.56%
1Y Performance:
-33.46%
1-Day Range:
$1.70
$1.805
1-Week Range:
$1.66
$1.89
52-Week Range:
$1.6001
$4.67
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
1.71 | 119.55M | 0 | -13.14M | -13.11M | -0.3056 |
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-26 | Initiated | B. Riley Securities | Buy |
| Dec-03-25 | Initiated | Roth Capital | Buy |
| Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
| Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
After plunging 22.6% in 4 weeks, here's why the trend might reverse for Microbot Medical (MBOT) - MSN
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT) - Yahoo Finance
Microbot Medical Inc stock (US5950101098): Liberty launch drives first-quarter revenue and raises in - AD HOC NEWS
Microbot Medical Inc. (MBOT) reports Q1 loss, misses revenue estimates - MSN
Microbot Medical stock (US5950101098): Cash runway, pipeline, and what investors are watching - AD HOC NEWS
Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Microbot Medical Inc stock (US5950101098): LIBERTY call and Q1 2026 numbers keep focus on robot-assi - AD HOC NEWS
Microbot Medical Schedules Call on LIBERTY System Progress - TipRanks
Microbot Medical to Host May 18 Call Addressing LIBERTY FMR Progress and Third‑Party Article - TradingView
Microbot Medical (NASDAQ: MBOT) sets investor call on LIBERTY progress and recent article - Stock Titan
Microbot Medical to host call addressing recent claims and progress of LIBERTY robotic system - Pluang
Microbot Medical Inc. to Host Conference Call Addressing Misrepresentations from Unaffiliated Third-Party Article - Quiver Quantitative
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu - The Manila Times
Doctors using Microbot’s LIBERTY robot to address article claims - Stock Titan
Microbot Medical (MBOT) Reports Q1 Loss and Faces Short Seller S - GuruFocus
Microbot Medical (MBOT) Faces Stock Plunge Amid Short Seller Rep - GuruFocus
Microbot Medical Inc stock (US5950101098): shares under pressure after short-seller report and weak - AD HOC NEWS
Microbot Medical plunges amid results, short report from White Diamond Research - MSN
Microbot Medical Reports First Revenue from LIBERTY System as Commercial Adoption Accelerates Across U.S. Hospitals 1 - Minichart
Microbot Medical stock drops after White Diamond short report By Investing.com - Investing.com Australia
Microbot Medical stock drops after White Diamond short report - Investing.com
Microbot Medical Launches Full Commercial LIBERTY System Rollout - TipRanks
Microbot Medical Q2 revenue surpasses Q1 after system launch - Investing.com
Microbot Medical Q2 revenue surpasses Q1 after system launch By Investing.com - Investing.com Australia
Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System - TradingView
Microbot Medical records Q1 revenue; Q2 mid-quarter revenue already exceeds Q1 as LIBERTY adoption grows - TradingView
Microbot Medical (NASDAQ: MBOT) sees LIBERTY system revenue rise in Q2 - Stock Titan
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 - GlobeNewswire
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Microbot Medical Inc. (MBOT) latest stock news and headlines - Yahoo Finance Singapore
Microbot Medical Inc. 1Q 2026: Revenue $105K, Net income $(3.67M) — 10-Q Summary - TradingView
Microbot Medical (NASDAQ: MBOT) starts LIBERTY robot sales with strong cash - Stock Titan
Microbot Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MBOT Stock Price, Quote & Chart | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill
TradingKey - TradingKey
MSN Money - MSN
Number of shareholders of Microbot Medical Inc. – NASDAQ:MBOT - TradingView
Microbot Medical Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday - MarketBeat
Microbot Medical’s LIBERTY System Gains Early Market Traction - TipRanks
Microbot Medical®'s Liberty® endovascular robotic system is now adopted by multiple accounts across key territories including two Access-PVI pivotal clinical trial sites - marketscreener.com
A blood-vessel robot lands 2 trial sites as its rollout expands - Stock Titan
Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites - TradingView
Microbot wins multiple LIBERTY system accounts, including two ACCESS-PVI trial sites - TradingView
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites - marketscreener.com
Microbot Medical (MBOT) gains new LIBERTY robotic adopters post-SIR - Stock Titan
Microbot Medical (NASDAQ:MBOT) Cut to "Strong Sell" at Wall Street Zen - MarketBeat
Microbot Medical Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia - marketscreener.com
Microbot Medical Inc. appoints Alon Tamir as VP Sales EMEA - Indian Pharma Post
Microbot Medical begins full US launch of LIBERTY system - MSN
Microbot Medical Expands EMEA Leadership for Global Growth - TipRanks
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):